"ProMedica's Mission is to improve your health and well-being. ProMedica Russell J. Ebeid Children's Hospital, formerly ProMedica Toledo Children's Hospital, takes that pledge very seriously. We are Toledo and our region’s only children’s hospital accredited by the Joint Commission! We’re a 151-bed facility in Toledo, Ohio, that caters to the hospitalization needs of infants, children and adolescents in northwest Ohio and southeast Michigan."

During the past decade, ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 121 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 48 clinical trials were completed. i.e. 252.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "Children's Oncology Group" with 81 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 131 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "Children's Oncology Group" with 6 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" are "Recurrent Neuroblastoma" (19 trials), "Recurrent Osteosarcoma" (15 trials), "Refractory Neuroblastoma" (15 trials), "Recurrent Malignant Solid Neoplasm" (14 trials) and "Refractory Malignant Solid Neoplasm" (14 trials). Many other conditions were trialed in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" in a lesser frequency.

Most popular intervention types in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" are "Drug" (234 trials), "Other" (153 trials), "Biological" (106 trials), "Procedure" (76 trials) and "Radiation" (59 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (103 trials), "Cyclophosphamide" (43 trials), "Quality-of-Life Assessment" (40 trials), "Radiation Therapy" (33 trials) and "Vincristine Sulfate" (33 trials). Other intervention names were less common.

The vast majority of trials in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital" are 245 trials for "All" genders, 31 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital". undefined are not yet recruiting, 50 are recruiting, 110 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 101 completed trials in ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, 3 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, 15 "Phase 1" clinical trials were conducted, 118 "Phase 2" clinical trials and 137 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".